Skip to main content
. 2021 Aug 15;13(8):9853–9859.

Table 4.

Clinical characteristics of cardiovascular-related adverse events

Etomidate group (n = 90) Propofol group (n = 90) P-value Significance
Tachycardia, n (%) 0 (0.00) 0 (0.00) NA n.s.
Transient hypertension, n (%) 6 (6.67) 1 (1.11) 0.118 n.s.
Bradycardia, n (%) 2 (2.22) 4 (4.44) 0.682 n.s.
Transient hypotension, n (%) 1 (1.11) 8 (8.89) 0.034 *

n.s.: no significance; *P<0.05.